GROSSMAN D KEITH — SEC Form 4 filings
SEC reporting owner CIK 1218702. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-05 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 38,117 shares, $144,234 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 26,230 shares @ $3.80 ($99,766) in Outset Medical, Inc., filed 2024-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | Director | 5 | — | 2 legs · 38,117 sh · $144,234 | 10 |
| NEVRO CORP (NVRO) | Director | 11 | — | — | 14 |
| MiniMed Group, Inc. (MMED) | Director | 1 | — | — | 1 |
Form 4 filings — GROSSMAN D KEITH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-03-11 | 4 | MiniMed Group, Inc. (MMED) | Grant/award (A): 13,889 @ $0 | EDGAR |
| 2025-06-04 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 8,983 @ $0 | EDGAR |
| 2025-04-03 | 4 | NEVRO CORP (NVRO) | Disposition to issuer (D): 228,552 | EDGAR |
| 2025-03-11 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,641 @ $5.78 | EDGAR |
| 2025-03-11 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 187,500 · Grant/award (A): 750 (derivative) @ $200 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,071 @ $5.72 · Tax withholding (F): 1,017 @ $5.72 | EDGAR |
| 2024-12-04 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 928 @ $4.26 | EDGAR |
| 2024-09-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,020 @ $5.55 | EDGAR |
| 2024-06-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,134 @ $9.33 | EDGAR |
| 2024-06-03 | 4 | Outset Medical, Inc. (OM) | Option exercise (M): 31,186 @ $1.11 · Sale (S): 26,230 @ $3.80 · Option exercise (M): 38,117 @ $1.11 · Sale (S): 11,887 @ $3.74 · Option exercise (M): 31,186 (derivative) @ $0 · Option exercise (M): 38,117 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2024-05-28 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 19,169 @ $0 | EDGAR |
| 2024-04-15 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 3,986 @ $13.12 | EDGAR |
| 2024-03-13 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 2,184 @ $14.99 | EDGAR |
| 2024-03-06 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 4,750 @ $0 · Tax withholding (F): 1,597 @ $14.51 | EDGAR |
| 2024-03-05 | 4 | NEVRO CORP (NVRO) | Tax withholding (F): 1,403 @ $14.22 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1218702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →